InnerworldM to Litigation SettlementsEnglish · 4 days agoChemoCentryx Inc. agreed to pay $35 million to settle an investor class action over alleged false statements it made regarding the safety of its vasculitis drugnews.bloomberglaw.comexternal-linkmessage-square0linkfedilinkarrow-up11arrow-down10
arrow-up11arrow-down1external-linkChemoCentryx Inc. agreed to pay $35 million to settle an investor class action over alleged false statements it made regarding the safety of its vasculitis drugnews.bloomberglaw.comInnerworldM to Litigation SettlementsEnglish · 4 days agomessage-square0linkfedilink
